![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 48, 45168-45174, November 30, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Molecular Oncology Laboratory, Department of Surgery, The
University of Chicago Medical Center, Chicago, Illinois 60637, the
§ Department of Biochemistry and Molecular Biology,
Chongqing University of Medical Sciences, Chongqing 400046, China, and
the ¶ Department of Orthopaedic Surgery, Yamagata University
School of Medicine, 2-2-2, Iida-Nishi, Yamagata 990-9585, Japan
Regulated gene expression will provide important
platforms from which gene functions can be investigated and safer means
of gene therapy may be developed. Histone deacetylases have recently been shown to play an important role in regulating gene expression. Here we investigated whether a more tightly controlled expression could
be achieved by using a novel chimeric repressor that recruits histone
deacetylases to a tetracycline-responsive promoter. This chimeric repressor was engineered by fusing the tetracycline repressor (TetR) with an mSin3-interacting domain of human Mad1 and was shown to
bind the tetO2 element with high affinity, and
its binding was efficiently abrogated by doxycycline. The chimeric
repressor was shown to directly interact with mSin3 of the histone
deacetylase complex. This inducible system was further simplified by
using a single vector that contained both a chimeric repressor
expression cassette and a tetracycline-responsive promoter. When
transiently introduced into mammalian cells, the chimeric repressor
system exhibited a significantly lower basal level of luciferase
activity (up to 25-fold) than that of the TetR control. When stably
transfected into HEK 293 cells, the chimeric repressor system was shown
to exert a tight control of green fluorescent protein expression in a
doxycycline dose- and time-dependent fashion. Therefore, this novel chimeric repressor provides an effective means for more
tightly regulated gene expression, and the simplified inducible system
may be used for a broad range of basic and clinical studies.
Tetracycline-regulated Gene Expression Mediated by a Novel
Chimeric Repressor That Recruits Histone Deacetylases in Mammalian
Cells*
,
§,
,
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
These authors contributed equally to this work.
To whom correspondence should be addressed: Molecular Oncology
Laboratory, The University of Chicago Medical Center, 5841 S. Maryland
Ave., MC 3079, Rm. J-611, Chicago, IL 60637. Tel: 773-702-7169; Fax:
773-834-4598; E-mail: tche@surgery.bsd.uchicago.edu.
This article has been cited by other articles:
![]() |
M. J. Ausserlechner, P. Obexer, A. Deutschmann, K. Geiger, and R. Kofler A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of antiproliferative and toxic genes. Mol. Cancer Ther., August 1, 2006; 5(8): 1927 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zabala, L. Wang, R. Hernandez-Alcoceba, W. Hillen, C. Qian, J. Prieto, and M. G. Kramer Optimization of the Tet-on System To Regulate Interleukin 12 Expression in the Liver for the Treatment of Hepatic Tumors Cancer Res., April 15, 2004; 64(8): 2799 - 2804. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |